Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IY
iShares U.S. Healthcare ETF
IYH
Volume
1.47M
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IY
IYH
IY
iShares U.S. Healthcare ETF
IYH
News
·
Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH?
AUM
N/A
Volume
1.47M
Yield
1.03%
Chart
Earnings
News
About
Dividends
Insider
Filings
Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH?
The article compares two healthcare ETFs: IBB (biotech-focused) and IYH (broad healthcare). IBB has delivered stronger 1-year returns (38% vs 17.4%) but exhibits higher volatility and deeper drawdowns. IYH offers lower costs, higher dividend yield, and broader diversification, making it better for most long-term investors, while IBB suits those with conviction in biotech momentum who can tolerate volatility.
The Motley Fool · Oct 11, 2026
IYH Beats IXJ on Returns While Global Fund Offers Higher Yield
iShares U.S. Healthcare ETF (IYH) outperformed its global counterpart (IXJ) with 28.8% one-year returns versus 22.5%, while IXJ offers higher dividend yield at 1.4%. Both funds have nearly identical expense ratios (0.37-0.38%) and low volatility, with choice depending on whether investors prefer domestic or international healthcare exposure.
The Motley Fool · Oct 6, 2026
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH
The Invesco Nasdaq Biotechnology ETF (IBBQ) offers lower costs (0.19% expense ratio) and higher 1-year returns (44.6%), making it suitable for growth-focused investors willing to accept volatility. The iShares U.S. Healthcare ETF (IYH) provides broader diversification across 100 healthcare holdings with higher dividend yield (1.1%) and lower volatility, appealing to conservative investors seeking stability and income.
The Motley Fool · Sep 23, 2026
Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?
The article compares two healthcare-focused ETFs from iShares: IHE (Pharmaceuticals ETF) with 55 holdings and IYH (Healthcare ETF) with 100 holdings. While IHE delivered stronger 1-year returns of 50% versus IYH's 27.4%, the article recommends IYH as the better choice due to superior 3- and 5-year performance, greater diversification, and larger asset base of $3.9B. Both funds have identical 0.37% expense ratios.
The Motley Fool · Sep 8, 2026
Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now?
Simplify Health Care ETF (PINK) has delivered superior 1-year returns of 42% versus iShares U.S. Healthcare ETF's (IYH) 31.4%, driven by active management focused on healthcare innovation and a charitable mission donating profits to cancer research. However, IYH offers lower costs (0.38% vs 0.51% expense ratio), higher dividend yield (1.1% vs 0.6%), and a proven 25+ year track record, making it the more suitable choice for most long-term conservative investors despite PINK's recent outperformance.
The Motley Fool · Aug 13, 2026
Healthcare Stocks Are Having a Good Year. Should You Buy a Fidelity or iShares ETF to Profit?
The article compares two healthcare-focused ETFs: Fidelity MSCI Health Care Index ETF (FHLC) and iShares U.S. Healthcare ETF (IYH). FHLC is recommended as the better choice due to its significantly lower expense ratio (0.08% vs 0.38%), broader diversification with 334 holdings versus 100, and consistent outperformance across multiple time periods. Over 10 years, a $10,000 investment in FHLC would have yielded approximately $1,900 more than IYH.
The Motley Fool · Aug 1, 2026
AbbVie's Early Obesity Drug Data Shows Up To 10% Weight Loss
AbbVie reported Phase 1 study results for ABBV-295, a long-acting amylin analog for obesity treatment, showing dose-dependent weight reductions of 7.75% to 9.79% at week 12 with generally mild side effects. Despite positive drug data, AbbVie shares traded lower on Monday amid broader market pressure.
Benzinga · Mar 9, 2026
ETFs to Secure Your Portfolio Amid Uncertain Market Conditions
Economists have raised the probability of a U.S. recession within the next 12 months, citing a disappointing jobs report and market volatility. However, JPMorgan Chase CEO Jamie Dimon believes the U.S. economy has not entered a recession, though the odds of one are more likely than not. Investors are advised to consider defensive sectors like quality, consumer staples, healthcare, and utilities to navigate the uncertain environment.
Zacks Investment Research · Aug 8, 2024
What Lies in Store for Healthcare ETFs in Q2 Earnings? - Zacks Investment Research
The healthcare sector has gained momentum recently, with investors rushing to buy beaten-down stocks. The performance of major healthcare ETFs like XLV, VHT, IYH, and FHLC will depend on the upcoming earnings releases of big names like Pfizer, Merck, Amgen, AbbVie, Bristol Myers Squibb, and Eli Lilly.
Zacks Investment Research · Jul 24, 2024
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
You don't need to be a stock market expert to earn above-average returns.
The Motley Fool · Jun 22, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
IY
IYH
iShares U.S. Healthcare ETF
Buy
Sell
Market
Limit
Soon
IYH
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any IYH yet.
Related Tickers
Earnings
Dividends
Last · Sep 15
Quarterly
Amount
$0.19
Yield
1.08%
Annual
$0.80